Das Point of Care Diagnosesystem der nächsten Generation!
ichroma™ ist ein kompakter, benutzerfreundlicher diagnostischer Immunanalysator zur Messung des Vorhandenseins verschiedener Biomarker für Herzerkrankungen, Krebs, Hormone, Infektionskrankheiten, Autoimmunerkrankungen und Stoffwechselerkrankungen.
Hohe Leistung mit Zuverlässigkeit
Hohe Leistung mit Zuverlässigkeit
Multitestfunktion
Multitestfunktion
Klein, kompakt und leicht
Klein, kompakt und leicht
LIS/HIS-kompatibel
LIS/HIS-kompatibel
Presse
ichroma™ II COVID-19 Ab-Testsystem
Der ichroma™ II COVID-19 Ab-Testsystem ist ein schneller in-vitro-diagnostischer Test zum qualitativen Nachweis von Anti-SARS-CoV-2 lgG/lgM-Antikörpern in Vollblut-, Serum- oder Plasmaproben mit hoher Sensitivität.
ichroma™ II COVID-19 Ab in Verbindung mit einem ichroma™ II Reader ist ein in-vitro-diagnostischer Fluoreszenz-Lmmunoassay zum qualitativen Nachweis und zur Differenzierung von lgG/lgM-Antikörpern gegen das neuartige Coronavirus SARS-CoV-2.
ichroma™ CRP wins a ‘World Class Product of Korea Year 2015 award’ co-hosted by KOTRA & MOTIE.
ichroma™ CRP marker has maintained its No. 1 market share in China thanks to its high quality and user-friendliness. CRP (C-reactive protein) is a useful marker to evaluate patients for an acute or chronic inflammatory condition. ichroma™ CRP test is performed on an ichroma analyzer, a fluorescence immune-assay instrument.
Since its global debut in 2005, the reagent along with the analyzer has been used at hospitals as well as doctor’s offices in over 80 countries.The system can analyze over 30 different tests including inflammation, cardiovascular diseases, caners, diabetes, thyroid malfunction, etc.
Boditech Med Inc. will continue its investment into R&D in order to develop additional world-class in-vitro diagnostics products.” MOTIE (Ministry of Trade, Industry and Energy) and KOTRA has hosted a “World Class Product of Korea Year 2015” award ceremony at COEX Grand Ballroom on Dec 16, 2015. Amidst 300 attendees including a vice mister of MOTIE and a vice president of KOTRA, ichroma CRP was awarded as today’s world-class product of Korea 2015.
The award is granted to qualified Korean products that are either among global top 5 players or whose market share is over 5% worldwide. MOTIE and KOTRA support the winners in a variety of aspects from R&D support to overseas marketing assistance.
Dr. Eui Yul Choi, CEO of Boditech Med Inc., has expressed his gratitude to MOFIE/KOTRA as well as his employees for the award. And he also affirmed his relentless endeavor to present exemplary IVD products that can lead the global in-vitro diagnostics market as a IVD pioneer in Korea.
